David Murphy
Concepts (364)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 29 | 2026 | 916 | 5.090 |
Why?
| | Critical Care | 12 | 2026 | 695 | 2.820 |
Why?
| | Critical Illness | 15 | 2026 | 891 | 2.250 |
Why?
| | Erythrocyte Transfusion | 6 | 2019 | 231 | 1.970 |
Why?
| | Organ Dysfunction Scores | 4 | 2023 | 53 | 1.480 |
Why?
| | Health Resources | 3 | 2016 | 129 | 1.250 |
Why?
| | Hospital Mortality | 13 | 2026 | 1030 | 1.090 |
Why?
| | Quality Indicators, Health Care | 3 | 2026 | 335 | 1.030 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2018 | 57 | 0.990 |
Why?
| | Delphi Technique | 3 | 2025 | 329 | 0.920 |
Why?
| | Sepsis | 8 | 2024 | 640 | 0.900 |
Why?
| | Common Data Elements | 1 | 2025 | 15 | 0.890 |
Why?
| | Quality Improvement | 4 | 2026 | 1289 | 0.850 |
Why?
| | Neurodevelopmental Disorders | 5 | 2026 | 227 | 0.840 |
Why?
| | Cross Infection | 3 | 2019 | 262 | 0.800 |
Why?
| | Wounds and Injuries | 3 | 2025 | 956 | 0.800 |
Why?
| | Multiple Organ Failure | 3 | 2019 | 124 | 0.740 |
Why?
| | Brain Diseases | 4 | 2024 | 152 | 0.720 |
Why?
| | Fluid Therapy | 3 | 2024 | 147 | 0.690 |
Why?
| | Computed Tomography Angiography | 3 | 2017 | 145 | 0.690 |
Why?
| | Bacterial Infections | 2 | 2021 | 246 | 0.650 |
Why?
| | Radiation Dosage | 2 | 2020 | 192 | 0.610 |
Why?
| | Humans | 88 | 2026 | 144759 | 0.600 |
Why?
| | Health Care Costs | 3 | 2020 | 427 | 0.600 |
Why?
| | Survivors | 1 | 2023 | 520 | 0.580 |
Why?
| | Movement Disorders | 3 | 2024 | 69 | 0.570 |
Why?
| | Coronary Angiography | 3 | 2017 | 323 | 0.570 |
Why?
| | Coronary Artery Disease | 4 | 2019 | 741 | 0.570 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2019 | 81 | 0.570 |
Why?
| | Systemic Inflammatory Response Syndrome | 2 | 2022 | 96 | 0.550 |
Why?
| | Ventilators, Mechanical | 2 | 2020 | 70 | 0.530 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2017 | 40 | 0.520 |
Why?
| | Mitral Valve Insufficiency | 1 | 2017 | 72 | 0.510 |
Why?
| | Mitral Valve | 1 | 2017 | 96 | 0.510 |
Why?
| | Hip Fractures | 1 | 2018 | 84 | 0.510 |
Why?
| | Respiration, Artificial | 4 | 2026 | 708 | 0.500 |
Why?
| | Phenotype | 12 | 2026 | 3162 | 0.500 |
Why?
| | Hemoglobins | 6 | 2019 | 384 | 0.490 |
Why?
| | Blood Transfusion | 2 | 2018 | 405 | 0.490 |
Why?
| | Intellectual Disability | 5 | 2026 | 175 | 0.490 |
Why?
| | Practice Patterns, Physicians' | 3 | 2021 | 1356 | 0.490 |
Why?
| | Physician Incentive Plans | 1 | 2016 | 8 | 0.480 |
Why?
| | United States Public Health Service | 1 | 2015 | 9 | 0.470 |
Why?
| | Albumins | 1 | 2016 | 118 | 0.470 |
Why?
| | Pneumonia, Viral | 4 | 2020 | 384 | 0.450 |
Why?
| | Middle Aged | 33 | 2026 | 35875 | 0.450 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2017 | 197 | 0.440 |
Why?
| | Hospitals | 2 | 2020 | 730 | 0.440 |
Why?
| | Radiology | 1 | 2017 | 174 | 0.430 |
Why?
| | Emergencies | 1 | 2015 | 175 | 0.430 |
Why?
| | Lung Diseases | 2 | 2024 | 787 | 0.410 |
Why?
| | Female | 43 | 2026 | 78271 | 0.410 |
Why?
| | Cardiac Catheterization | 1 | 2017 | 560 | 0.410 |
Why?
| | Cardiomyopathies | 1 | 2017 | 338 | 0.390 |
Why?
| | Developmental Disabilities | 3 | 2024 | 281 | 0.390 |
Why?
| | Male | 41 | 2026 | 72315 | 0.390 |
Why?
| | Guideline Adherence | 3 | 2016 | 589 | 0.380 |
Why?
| | Spastic Paraplegia, Hereditary | 2 | 2022 | 12 | 0.370 |
Why?
| | Catheter-Related Infections | 2 | 2010 | 94 | 0.370 |
Why?
| | Microcephaly | 2 | 2024 | 103 | 0.370 |
Why?
| | Data Collection | 1 | 2015 | 633 | 0.360 |
Why?
| | Evidence-Based Medicine | 2 | 2013 | 732 | 0.360 |
Why?
| | Retrospective Studies | 19 | 2026 | 17066 | 0.360 |
Why?
| | Aged | 24 | 2026 | 25913 | 0.350 |
Why?
| | Emergency Medical Services | 2 | 2016 | 696 | 0.350 |
Why?
| | Catheterization, Central Venous | 2 | 2010 | 122 | 0.350 |
Why?
| | Evidence-Based Practice | 1 | 2014 | 238 | 0.350 |
Why?
| | APACHE | 4 | 2026 | 66 | 0.340 |
Why?
| | Coronavirus Infections | 3 | 2020 | 378 | 0.340 |
Why?
| | Hospitalization | 7 | 2022 | 2433 | 0.330 |
Why?
| | Mitochondrial Diseases | 2 | 2022 | 93 | 0.330 |
Why?
| | Societies, Hospital | 1 | 2010 | 1 | 0.320 |
Why?
| | Consensus | 3 | 2025 | 488 | 0.320 |
Why?
| | Water-Electrolyte Imbalance | 2 | 2025 | 42 | 0.320 |
Why?
| | Severity of Illness Index | 6 | 2026 | 2925 | 0.320 |
Why?
| | Tomography, X-Ray Computed | 4 | 2024 | 2730 | 0.310 |
Why?
| | Aged, 80 and over | 9 | 2021 | 8265 | 0.300 |
Why?
| | Epilepsy | 2 | 2023 | 376 | 0.280 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2009 | 98 | 0.280 |
Why?
| | Delivery of Health Care | 1 | 2015 | 947 | 0.270 |
Why?
| | Adult | 21 | 2025 | 40449 | 0.260 |
Why?
| | Betacoronavirus | 2 | 2020 | 286 | 0.260 |
Why?
| | Machine Learning | 4 | 2026 | 585 | 0.260 |
Why?
| | Hospital Costs | 2 | 2019 | 124 | 0.250 |
Why?
| | Maryland | 2 | 2018 | 66 | 0.240 |
Why?
| | Parkinsonian Disorders | 1 | 2026 | 43 | 0.230 |
Why?
| | Genetic Heterogeneity | 1 | 2026 | 62 | 0.230 |
Why?
| | Acute Lung Injury | 1 | 2009 | 303 | 0.230 |
Why?
| | Electronic Health Records | 5 | 2024 | 1173 | 0.230 |
Why?
| | Catechol O-Methyltransferase | 1 | 2025 | 20 | 0.230 |
Why?
| | Mediator Complex | 2 | 2023 | 61 | 0.220 |
Why?
| | Quality of Health Care | 3 | 2021 | 691 | 0.220 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2026 | 159 | 0.220 |
Why?
| | Length of Stay | 3 | 2025 | 1337 | 0.220 |
Why?
| | United States | 15 | 2021 | 15966 | 0.220 |
Why?
| | Unsupervised Machine Learning | 1 | 2025 | 22 | 0.220 |
Why?
| | Pneumonia | 2 | 2010 | 631 | 0.220 |
Why?
| | Medication Therapy Management | 1 | 2025 | 73 | 0.210 |
Why?
| | Mutation | 9 | 2026 | 4089 | 0.210 |
Why?
| | Infection Control | 3 | 2018 | 172 | 0.210 |
Why?
| | Patient Satisfaction | 1 | 2009 | 704 | 0.210 |
Why?
| | Coronary Vessels | 2 | 2016 | 251 | 0.210 |
Why?
| | Epilepsy, Generalized | 1 | 2023 | 19 | 0.200 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2023 | 18 | 0.200 |
Why?
| | Nervous System Malformations | 1 | 2024 | 47 | 0.200 |
Why?
| | Intra-Abdominal Fat | 1 | 2024 | 100 | 0.200 |
Why?
| | Prognosis | 3 | 2023 | 4282 | 0.200 |
Why?
| | Cysts | 1 | 2024 | 111 | 0.200 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2023 | 44 | 0.200 |
Why?
| | Continuous Positive Airway Pressure | 1 | 2024 | 88 | 0.200 |
Why?
| | Resuscitation | 2 | 2024 | 302 | 0.200 |
Why?
| | Membrane Transport Proteins | 1 | 2024 | 154 | 0.200 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2024 | 146 | 0.190 |
Why?
| | Systems Analysis | 1 | 2023 | 22 | 0.190 |
Why?
| | Positron Emission Tomography Computed Tomography | 3 | 2024 | 117 | 0.190 |
Why?
| | Abnormalities, Multiple | 1 | 2024 | 197 | 0.190 |
Why?
| | Pharmacists | 2 | 2022 | 240 | 0.190 |
Why?
| | Child, Preschool | 11 | 2026 | 11787 | 0.190 |
Why?
| | Cell Division | 1 | 2024 | 766 | 0.190 |
Why?
| | Information Dissemination | 1 | 2025 | 223 | 0.190 |
Why?
| | Dystonia | 1 | 2022 | 28 | 0.190 |
Why?
| | Neural Stem Cells | 1 | 2024 | 166 | 0.190 |
Why?
| | Pandemics | 5 | 2021 | 1694 | 0.180 |
Why?
| | Apyrase | 1 | 2022 | 26 | 0.180 |
Why?
| | Hearing Loss | 1 | 2026 | 247 | 0.180 |
Why?
| | Parkinson Disease | 2 | 2026 | 600 | 0.180 |
Why?
| | Patient Safety | 1 | 2026 | 347 | 0.180 |
Why?
| | Connective Tissue Diseases | 1 | 2022 | 84 | 0.180 |
Why?
| | Pedigree | 4 | 2026 | 514 | 0.180 |
Why?
| | beta Karyopherins | 1 | 2021 | 9 | 0.170 |
Why?
| | Community Pharmacy Services | 1 | 2021 | 46 | 0.170 |
Why?
| | Pharmacy | 1 | 2021 | 33 | 0.170 |
Why?
| | Resource Allocation | 1 | 2021 | 53 | 0.170 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2024 | 276 | 0.170 |
Why?
| | Loss of Heterozygosity | 1 | 2021 | 52 | 0.170 |
Why?
| | ROC Curve | 1 | 2023 | 614 | 0.170 |
Why?
| | Infant | 9 | 2026 | 10034 | 0.170 |
Why?
| | Loss of Function Mutation | 1 | 2021 | 46 | 0.170 |
Why?
| | Calcium-Binding Proteins | 1 | 2022 | 219 | 0.170 |
Why?
| | Pharmaceutical Services | 1 | 2021 | 78 | 0.170 |
Why?
| | Cataract | 1 | 2023 | 238 | 0.160 |
Why?
| | Pharmacy Service, Hospital | 1 | 2021 | 81 | 0.160 |
Why?
| | Cannula | 1 | 2020 | 27 | 0.160 |
Why?
| | Health Care Surveys | 2 | 2014 | 539 | 0.160 |
Why?
| | Pneumonia, Bacterial | 1 | 2021 | 113 | 0.160 |
Why?
| | Retinal Diseases | 1 | 2021 | 101 | 0.160 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 151 | 0.160 |
Why?
| | White Matter | 1 | 2022 | 153 | 0.160 |
Why?
| | Genetic Predisposition to Disease | 2 | 2026 | 2363 | 0.160 |
Why?
| | Immunomodulation | 1 | 2020 | 101 | 0.150 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2024 | 300 | 0.150 |
Why?
| | Coinfection | 1 | 2021 | 141 | 0.150 |
Why?
| | Medical Overuse | 1 | 2020 | 30 | 0.150 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2019 | 30 | 0.150 |
Why?
| | Urinalysis | 1 | 2020 | 80 | 0.150 |
Why?
| | DNA, Mitochondrial | 1 | 2021 | 211 | 0.150 |
Why?
| | Quality Assurance, Health Care | 3 | 2010 | 340 | 0.150 |
Why?
| | Hematocrit | 1 | 2019 | 108 | 0.150 |
Why?
| | Aortic Aneurysm, Thoracic | 1 | 2021 | 139 | 0.150 |
Why?
| | Socioenvironmental Therapy | 1 | 2019 | 2 | 0.150 |
Why?
| | Nuclear Proteins | 1 | 2024 | 748 | 0.150 |
Why?
| | DNA Methylation | 1 | 2024 | 681 | 0.150 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2019 | 71 | 0.150 |
Why?
| | Health Equity | 1 | 2021 | 129 | 0.150 |
Why?
| | Syndrome | 3 | 2026 | 380 | 0.150 |
Why?
| | Cohort Studies | 6 | 2026 | 5960 | 0.140 |
Why?
| | Economics, Hospital | 1 | 2019 | 29 | 0.140 |
Why?
| | Weight Loss | 1 | 2024 | 836 | 0.140 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2020 | 182 | 0.140 |
Why?
| | Diagnostic Techniques and Procedures | 1 | 2018 | 19 | 0.140 |
Why?
| | Artificial Intelligence | 1 | 2023 | 365 | 0.140 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2019 | 136 | 0.140 |
Why?
| | Academic Medical Centers | 3 | 2022 | 547 | 0.140 |
Why?
| | New Jersey | 1 | 2018 | 16 | 0.140 |
Why?
| | Clinical Protocols | 2 | 2017 | 282 | 0.140 |
Why?
| | Kentucky | 1 | 2018 | 39 | 0.140 |
Why?
| | Adolescent | 11 | 2026 | 22428 | 0.140 |
Why?
| | Nutrition Assessment | 1 | 2018 | 92 | 0.140 |
Why?
| | Anemia | 1 | 2019 | 188 | 0.140 |
Why?
| | Medical Audit | 2 | 2017 | 77 | 0.140 |
Why?
| | Bacteremia | 2 | 2010 | 221 | 0.140 |
Why?
| | Nervous System Diseases | 1 | 2021 | 284 | 0.130 |
Why?
| | Acute Coronary Syndrome | 2 | 2019 | 293 | 0.130 |
Why?
| | Plasma | 1 | 2019 | 225 | 0.130 |
Why?
| | Intubation, Intratracheal | 1 | 2020 | 320 | 0.130 |
Why?
| | Washington | 1 | 2018 | 147 | 0.130 |
Why?
| | Hematologic Neoplasms | 1 | 2019 | 161 | 0.130 |
Why?
| | Urinary Tract Infections | 1 | 2020 | 202 | 0.130 |
Why?
| | Clinical Decision-Making | 1 | 2021 | 359 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2024 | 1720 | 0.130 |
Why?
| | Hospitals, University | 1 | 2017 | 176 | 0.130 |
Why?
| | Preoperative Period | 1 | 2017 | 149 | 0.130 |
Why?
| | Shock, Hemorrhagic | 1 | 2019 | 201 | 0.130 |
Why?
| | Child | 10 | 2026 | 22633 | 0.120 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2016 | 21 | 0.120 |
Why?
| | Prospective Studies | 4 | 2016 | 7990 | 0.120 |
Why?
| | Risk Factors | 5 | 2021 | 10779 | 0.120 |
Why?
| | Drug Utilization Review | 1 | 2016 | 61 | 0.120 |
Why?
| | Arteritis | 1 | 2016 | 25 | 0.120 |
Why?
| | Cost Savings | 1 | 2016 | 86 | 0.120 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2019 | 266 | 0.120 |
Why?
| | Residence Characteristics | 1 | 2019 | 377 | 0.120 |
Why?
| | Zebrafish | 3 | 2026 | 528 | 0.110 |
Why?
| | Fracture Fixation, Internal | 1 | 2018 | 207 | 0.110 |
Why?
| | Heart Neoplasms | 1 | 2015 | 55 | 0.110 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2018 | 182 | 0.110 |
Why?
| | Respiratory Insufficiency | 2 | 2020 | 326 | 0.110 |
Why?
| | Patient Outcome Assessment | 1 | 2015 | 134 | 0.110 |
Why?
| | Burns | 1 | 2019 | 377 | 0.110 |
Why?
| | Interdisciplinary Communication | 1 | 2015 | 197 | 0.100 |
Why?
| | Baltimore | 1 | 2014 | 71 | 0.100 |
Why?
| | Shock | 1 | 2015 | 108 | 0.100 |
Why?
| | Regression Analysis | 1 | 2016 | 1003 | 0.100 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1560 | 0.100 |
Why?
| | Medical Staff, Hospital | 1 | 2014 | 80 | 0.100 |
Why?
| | Health Services Needs and Demand | 1 | 2015 | 280 | 0.100 |
Why?
| | Drosophila melanogaster | 2 | 2026 | 236 | 0.100 |
Why?
| | Brain Injuries, Traumatic | 1 | 2019 | 441 | 0.100 |
Why?
| | Time Factors | 3 | 2022 | 7173 | 0.100 |
Why?
| | Injury Severity Score | 1 | 2015 | 600 | 0.100 |
Why?
| | Animals | 9 | 2026 | 38058 | 0.100 |
Why?
| | Carcinoma, Renal Cell | 1 | 2015 | 234 | 0.100 |
Why?
| | Confidence Intervals | 1 | 2013 | 333 | 0.090 |
Why?
| | Age Factors | 2 | 2017 | 3333 | 0.090 |
Why?
| | Acidosis | 1 | 2013 | 105 | 0.090 |
Why?
| | Organizational Culture | 2 | 2010 | 162 | 0.090 |
Why?
| | Paraplegia | 2 | 2022 | 61 | 0.090 |
Why?
| | Nursing Staff, Hospital | 1 | 2014 | 158 | 0.090 |
Why?
| | Autoimmune Diseases | 1 | 2016 | 463 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2020 | 1907 | 0.090 |
Why?
| | Immunoglobulin G | 1 | 2016 | 893 | 0.090 |
Why?
| | Program Evaluation | 1 | 2016 | 948 | 0.090 |
Why?
| | Kidney Neoplasms | 1 | 2015 | 412 | 0.080 |
Why?
| | Young Adult | 6 | 2025 | 14105 | 0.080 |
Why?
| | Patient Discharge | 1 | 2018 | 983 | 0.080 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2013 | 285 | 0.080 |
Why?
| | Treatment Outcome | 3 | 2020 | 11679 | 0.080 |
Why?
| | Obesity | 1 | 2024 | 3077 | 0.080 |
Why?
| | Odds Ratio | 1 | 2013 | 1075 | 0.080 |
Why?
| | Disease Models, Animal | 3 | 2026 | 4557 | 0.080 |
Why?
| | Diet | 1 | 2018 | 1273 | 0.080 |
Why?
| | Checklist | 1 | 2010 | 107 | 0.080 |
Why?
| | Fibroblasts | 2 | 2026 | 1034 | 0.070 |
Why?
| | Safety Management | 1 | 2010 | 121 | 0.070 |
Why?
| | Medical Errors | 1 | 2009 | 118 | 0.070 |
Why?
| | Cardiac Surgical Procedures | 1 | 2014 | 609 | 0.070 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1414 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 396 | 0.070 |
Why?
| | Mitochondria | 2 | 2026 | 984 | 0.070 |
Why?
| | Lung | 1 | 2020 | 4109 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2019 | 2168 | 0.060 |
Why?
| | Brain | 3 | 2024 | 2933 | 0.060 |
Why?
| | Workload | 1 | 2009 | 170 | 0.060 |
Why?
| | Membrane Proteins | 2 | 2024 | 1166 | 0.060 |
Why?
| | Biomarkers | 1 | 2018 | 4271 | 0.060 |
Why?
| | Decision Making | 1 | 2014 | 975 | 0.060 |
Why?
| | Mice | 4 | 2026 | 18339 | 0.060 |
Why?
| | Connexin 26 | 1 | 2026 | 9 | 0.060 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2026 | 75 | 0.060 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2947 | 0.060 |
Why?
| | Oregon | 1 | 2025 | 76 | 0.060 |
Why?
| | North Carolina | 1 | 2025 | 128 | 0.060 |
Why?
| | Emergency Service, Hospital | 1 | 2017 | 2310 | 0.060 |
Why?
| | Anti-Inflammatory Agents | 1 | 2008 | 474 | 0.060 |
Why?
| | Ethanolamine | 1 | 2024 | 6 | 0.050 |
Why?
| | Birt-Hogg-Dube Syndrome | 1 | 2024 | 8 | 0.050 |
Why?
| | Genes, Dominant | 1 | 2024 | 101 | 0.050 |
Why?
| | Genes, Recessive | 1 | 2024 | 78 | 0.050 |
Why?
| | N-Terminal Acetyltransferase F | 1 | 2024 | 1 | 0.050 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2024 | 5 | 0.050 |
Why?
| | Proof of Concept Study | 1 | 2024 | 85 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2008 | 535 | 0.050 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2024 | 36 | 0.050 |
Why?
| | Lymphangioleiomyomatosis | 1 | 2024 | 36 | 0.050 |
Why?
| | Receptors, Virus | 1 | 2024 | 96 | 0.050 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2024 | 64 | 0.050 |
Why?
| | Inheritance Patterns | 1 | 2024 | 44 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2024 | 133 | 0.050 |
Why?
| | Single-Blind Method | 1 | 2024 | 312 | 0.050 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2024 | 156 | 0.050 |
Why?
| | Cell Polarity | 1 | 2024 | 137 | 0.050 |
Why?
| | Choline | 1 | 2024 | 136 | 0.050 |
Why?
| | Tremor | 1 | 2024 | 98 | 0.050 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2024 | 118 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 367 | 0.050 |
Why?
| | Acetylation | 1 | 2024 | 252 | 0.050 |
Why?
| | Atrophy | 1 | 2023 | 201 | 0.050 |
Why?
| | Glycosylation | 1 | 2023 | 172 | 0.050 |
Why?
| | Phosphates | 1 | 2024 | 180 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2025 | 212 | 0.050 |
Why?
| | Vesicular Monoamine Transport Proteins | 1 | 2022 | 9 | 0.050 |
Why?
| | Spectrin | 1 | 2022 | 14 | 0.050 |
Why?
| | Neurogenesis | 1 | 2024 | 156 | 0.050 |
Why?
| | Amines | 1 | 2022 | 39 | 0.050 |
Why?
| | Dysarthria | 1 | 2022 | 10 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 69 | 0.050 |
Why?
| | Nervous System | 1 | 2022 | 70 | 0.050 |
Why?
| | Homozygote | 1 | 2022 | 199 | 0.040 |
Why?
| | Immunoglobulins, Intravenous | 1 | 2022 | 126 | 0.040 |
Why?
| | Cerebellum | 1 | 2023 | 223 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2023 | 521 | 0.040 |
Why?
| | Alleles | 1 | 2024 | 879 | 0.040 |
Why?
| | Follow-Up Studies | 2 | 2021 | 5408 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2024 | 437 | 0.040 |
Why?
| | Mortality | 2 | 2017 | 375 | 0.040 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2008 | 920 | 0.040 |
Why?
| | Time | 1 | 2020 | 86 | 0.040 |
Why?
| | Georgia | 1 | 2020 | 83 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2020 | 140 | 0.040 |
Why?
| | Professional Role | 1 | 2021 | 158 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 289 | 0.040 |
Why?
| | Pyuria | 1 | 2020 | 5 | 0.040 |
Why?
| | Disease Management | 1 | 2024 | 645 | 0.040 |
Why?
| | Mitochondrial Proteins | 1 | 2022 | 262 | 0.040 |
Why?
| | Morbidity | 1 | 2021 | 323 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2024 | 1489 | 0.040 |
Why?
| | Catheters, Indwelling | 2 | 2010 | 96 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2024 | 684 | 0.040 |
Why?
| | Inappropriate Prescribing | 1 | 2020 | 63 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2022 | 337 | 0.040 |
Why?
| | Seizures | 1 | 2022 | 460 | 0.040 |
Why?
| | Safety | 1 | 2020 | 356 | 0.040 |
Why?
| | Homeostasis | 1 | 2022 | 640 | 0.030 |
Why?
| | Transforming Growth Factor beta | 1 | 2021 | 479 | 0.030 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2025 | 2145 | 0.030 |
Why?
| | Insurance Claim Reporting | 1 | 2017 | 25 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2022 | 579 | 0.030 |
Why?
| | Lung Diseases, Interstitial | 1 | 2024 | 660 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2025 | 3604 | 0.030 |
Why?
| | Clinical Coding | 1 | 2017 | 25 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2026 | 1982 | 0.030 |
Why?
| | Education, Distance | 1 | 2018 | 61 | 0.030 |
Why?
| | Societies, Medical | 1 | 2021 | 887 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1326 | 0.030 |
Why?
| | RNA | 1 | 2022 | 940 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 2089 | 0.030 |
Why?
| | Population Surveillance | 1 | 2019 | 485 | 0.030 |
Why?
| | Comorbidity | 1 | 2020 | 1658 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2020 | 1053 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 6048 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 901 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 3121 | 0.030 |
Why?
| | Rats | 1 | 2022 | 5597 | 0.030 |
Why?
| | Coronary Artery Bypass | 1 | 2016 | 268 | 0.030 |
Why?
| | Research Design | 1 | 2018 | 1135 | 0.020 |
Why?
| | Algorithms | 1 | 2020 | 1837 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2834 | 0.020 |
Why?
| | Hospital Administration | 1 | 2010 | 26 | 0.020 |
Why?
| | Incidence | 1 | 2017 | 2879 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3409 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2015 | 2115 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2021 | 5992 | 0.020 |
Why?
| | Inservice Training | 1 | 2010 | 117 | 0.020 |
Why?
| | Problem Solving | 1 | 2010 | 156 | 0.020 |
Why?
| | Program Development | 1 | 2010 | 370 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 5226 | 0.020 |
Why?
| | Cooperative Behavior | 1 | 2010 | 465 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2008 | 574 | 0.020 |
Why?
| | Leadership | 1 | 2010 | 408 | 0.010 |
Why?
| | Risk | 1 | 2008 | 911 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2016 | 5868 | 0.010 |
Why?
| | Patient Care Team | 1 | 2010 | 689 | 0.010 |
Why?
| | Fractures, Bone | 1 | 2008 | 414 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2013 | 6429 | 0.010 |
Why?
|
|
Murphy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|